| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 07/10/2013 | CN1970571B G-csf analog compositions and methods |
| 07/10/2013 | CN103200947A Oncolytic measles virus |
| 07/10/2013 | CN103194472A Porcine epizootic diarrhea virus S1 protein fusion gene and recombinant bacillus megaterium, and their use |
| 07/10/2013 | CN103194471A Swine transmissible gastroenteritis virus S/N protein fusion gene and recombinant lactococcus lactis, and their use |
| 07/10/2013 | CN103194470A Swine transmissible gastroenteritis virus antigen fusion gene and recombinant bacillus megaterium, and their use |
| 07/10/2013 | CN103193888A Crystal structure of neuropil protein fragment and neuropil protein antibody compound |
| 07/10/2013 | CN103193887A Recombinant porcine IL2-Fc (interteukin-2-Fc) fusion protein as well as encoding gene and expressing method of fusion protein |
| 07/10/2013 | CN103193871A Method for designing novel TALE (transcription activator like effector) according to protein-DNA compound crystal structure |
| 07/10/2013 | CN101643511B Fusion protein for inhibiting telomerase activity, preparation and application thereof |
| 07/09/2013 | US8481041 Dock-and-lock (DNL) constructs for human immunodeficiency virus (HIV) therapy |
| 07/09/2013 | CA2506538C Bacterial superantigen vaccines |
| 07/09/2013 | CA2430702C Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 07/04/2013 | WO2013102187A1 Methods and compositions for diagnosing and treating cancer |
| 07/04/2013 | WO2013101915A1 Domain swapping modules |
| 07/04/2013 | WO2013100702A1 Immunoglobulin fc variants |
| 07/04/2013 | WO2013100580A1 Novel fusion protein binding to wnt |
| 07/04/2013 | WO2013100534A1 Protein complex and method of preparing same |
| 07/04/2013 | WO2013098339A1 Anti-tumor adjuvant therapy |
| 07/04/2013 | WO2013098337A1 Cell-penetrating peptides |
| 07/04/2013 | WO2013067160A3 Anti-bacterial polypeptides and pathogen specific synthetic antibodies |
| 07/04/2013 | US20130171727 T1r taste receptors and genes encoding same |
| 07/03/2013 | CN103189386A Recombinant envelope protein of human immunodeficiency virus (hiv) and vaccine containing the same |
| 07/03/2013 | CN103184230A Fusion protein gene TAT-sVP7 and application thereof |
| 07/03/2013 | CN103184229A Recombinant protein A/G gene and preparation and application of expression product of recombinant protein A/G gene |
| 07/03/2013 | CN102512674B Fish broad-spectrum vibrio subunit vaccine and preparation method |
| 07/03/2013 | CN101481406B H5 subtype avian influenza virus neutralization epitope peptide mimics and uses thereof |
| 07/03/2013 | CN101268102B Tissue inhibitor of metalloproteinases (TIMP) linked to glycosylphosphatidylinositol (GPI) -anchors for treatment of cancer and skin lesions |
| 07/02/2013 | US8475794 Combination therapy with anti-CD74 antibodies provides enhanced toxicity to malignancies, Autoimmune disease and other diseases |
| 07/02/2013 | US8475792 Molecules with extended half-lives, compositions and uses thereof |
| 07/02/2013 | CA2505558C T cell receptor display |
| 07/02/2013 | CA2408302C Long wavelength engineered fluorescent proteins |
| 06/27/2013 | WO2013096859A1 Methods and g proteins for screening and identifying ligands of g protein-coupled receptors |
| 06/27/2013 | WO2013094697A1 Anti-tumor peptide and use therefor |
| 06/27/2013 | WO2013094359A1 Cellulose-/chitin-type polymeric light-emitting material |
| 06/27/2013 | WO2013091577A1 Hybrid polypeptides having cellobiohydrolase activity and polynucleotides encoding same |
| 06/27/2013 | WO2013091004A1 Prevention and treatment of mycobacterium infection |
| 06/27/2013 | US20130165634 Expression and export of angiogenesis inhibitors as immunofusins |
| 06/27/2013 | US20130164823 Expression System |
| 06/27/2013 | US20130164733 Hepatitis-c virus testing |
| 06/27/2013 | US20130164286 Fc FUSION PROTEINS |
| 06/27/2013 | US20130164257 Multi-level specific targeting of cancer cells |
| 06/27/2013 | CA2858963A1 Vaccines against hpv |
| 06/26/2013 | EP2607380A2 Fusion protein having transcription factor transactivation-regulating domain and protein transduction domain, and transcription factor function inhibitor comprising the same |
| 06/26/2013 | EP2605783A1 Oncolytic measles virus |
| 06/26/2013 | CN103180344A Fusion protein having factor ix activity |
| 06/26/2013 | CN103180343A Composition for preventing or treating cervical cancer having human papillomavirus plasmodium and immunity enhancer |
| 06/26/2013 | CN103173478A Preparation method for anti-human CD3 single-chain antibody carrying PTD (protein transduction domain) |
| 06/26/2013 | CN103173477A Method for stably expressing recombined human serum albumin and human parathyroid hormone (1-34)ab diad fusion protein by using saccharomyces cerevisiae |
| 06/26/2013 | CN103172753A Fusion protein of GFE-1 and rmhTNF (recombinant mutant human Tumor Necrosis Factor) alpha and preparation method thereof |
| 06/26/2013 | CN103172752A Mycoplasma bovis diagnosis reagent and its application |
| 06/26/2013 | CN103172751A Fusion protein of PA4-Fc and coding gene and application thereof |
| 06/26/2013 | CN103172750A Immunosuppressive polypeptides and nucleic acids |
| 06/26/2013 | CN103172749A Preparation of African swine fever protein engineering vaccine |
| 06/26/2013 | CN103172748A Anti-malignant lymphoma fusion protein and preparation method thereof |
| 06/26/2013 | CN103172747A Conjugates of biologically active proteins having a modified in vivo half-life |
| 06/26/2013 | CN103172746A Tripolymer fc fusion proteins and use thereof |
| 06/26/2013 | CN103169986A Mosaic type DNA (Deoxyribonucleic Acid) vaccine pVAXI-Hsp 70/CD 80 for preventing and immunologically treating tuberculosis |
| 06/26/2013 | CN102268093B Fusion protein of hepatic-targeted peptide and human interferon a2b, and preparation method and application thereof |
| 06/26/2013 | CN102153655B Targeted anti-tumor recombinant protein and preparation method thereof |
| 06/26/2013 | CN101200727B Farm crop fungus resistant polypeptides and method for making same |
| 06/25/2013 | US8470970 Mammalian sweet and amino acid heterodimeric taste receptors comprising T1R3 and T1R1 |
| 06/25/2013 | US8470317 B7RP-1 antagonists |
| 06/25/2013 | CA2653566C Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 06/25/2013 | CA2492097C Signal for packaging of influenza virus vectors |
| 06/25/2013 | CA2454578C Modified human thymic stromal lymphopoietin |
| 06/20/2013 | WO2013089738A1 Compositions and methods for exosome targeted expression |
| 06/20/2013 | WO2013087922A1 Methods for producing engineered fluorescent proteins for enhanced fret, products and uses thereof |
| 06/20/2013 | WO2013086636A1 Soluble igf receptor fc fusion proteins and uses thereof |
| 06/20/2013 | WO2013086583A1 Assay and method for identifying compounds that inhibit excitotoxic signals |
| 06/20/2013 | WO2013062365A3 Mutant ctla4 gene transfected t cell and composition including same for anticancer immunotherapy |
| 06/20/2013 | WO2013022808A3 Immunogenic protein conjugates and methods for making and using the same |
| 06/20/2013 | US20130158234 Specific binding agents of human angiopoietin-2 |
| 06/20/2013 | US20130158232 Method for selecting a candidate drug compound |
| 06/20/2013 | US20130157927 Cysteine cross-linked structural peptides |
| 06/20/2013 | US20130156696 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse |
| 06/20/2013 | US20130156695 Use of zcytor17 ligand antagonists for treating inflammatory diseases |
| 06/20/2013 | DE102011121237A1 Einzeldomänen-Antikörper gegen Clostridium difficile Toxin CDTa Single domain antibodies against Clostridium difficile toxin CDTa |
| 06/20/2013 | CA2858389A1 Soluble igf receptor fc fusion proteins and uses thereof |
| 06/19/2013 | EP2604629A1 Composition for preventing or treating cervical cancer having human papillomavirus plasmodium and immunity enhancer |
| 06/19/2013 | EP2603520A2 Erythrocyte-binding therapeutics |
| 06/19/2013 | CN103160531A NGR-VEGI fusion protein as well as encoding gene and expression and purification method thereof |
| 06/19/2013 | CN103160530A Fusion gene and applications thereof |
| 06/19/2013 | CN103160519A Staphylococcus aureus enterotoxin B (SEB) immune preparation and its preparation method and use |
| 06/19/2013 | CN103159860A Recombinant tissue-type plasminogen activator, and preparation method and use thereof |
| 06/19/2013 | CN103159859A Sendai virus antigen peptide composition and application thereof in detecting Sendai virus infection |
| 06/19/2013 | CN103159858A Swine fever branch peptide and application thereof |
| 06/19/2013 | CN103159857A Compound based on recombinational triple helix support |
| 06/19/2013 | CN103159856A Preparation method of new antibiotic and platform system based on method |
| 06/19/2013 | CN103159855A Fusion protein, use thereof, and anti-malarial vaccine and antibody thereof |
| 06/19/2013 | CN102775478B Foot and mouth disease virus antigen peptide and vaccine |
| 06/19/2013 | CN102260698B PTA-linker-thanatin fusion protein expressed in escherichia coli, and anticancer research thereof |
| 06/19/2013 | CN101948545B IgG antibody affinity peptide-alkaline phosphatase fusion protein |
| 06/19/2013 | CN101915835B Lily mottle virus double-antibody sandwich enzyme-linked immunosorbent assay kit and preparation method |
| 06/19/2013 | CN101899460B Method for preparing fusion protein capable of lowering food allergen reaction |
| 06/19/2013 | CN101899116B Non-invasive high-penetrability epidermal growth factor and application thereof |
| 06/19/2013 | CN101819201B Polypeptide composition for detecting immune antibody of rheumatoid arthritis in vitro |
| 06/19/2013 | CN101717449B Recombinant TRAIL-Fc fusion protein as well as preparation and application thereof |
| 06/19/2013 | CN101514232B RANKL-Fc fusion protein, preparation method and application thereof |
| 06/19/2013 | CN101503475B Fusion protein of anthrax lethal factor domain (LFn) and anthrax edema factor domain (EFn) and use thereof |
| 06/19/2013 | CN101432428B Recombinant human interferon-like proteins |